摘要
[目的]探讨康复新液治疗糜烂性龟头炎的临床疗效。[方法]以66例糜烂性龟头炎患者为研究对象,随机分为实验组(n=33)与对照组(n=33)。实验组给予康复新液治疗,对照组给予百多邦软膏治疗,比较两组临床疗效、不良反应、生活质量及复发情况。[结果]有效率实验组90.91%(32/33),对照组66.67%(22/33),差异具有统计学意义(P<0.05);不良反应发生率实验组3.03%(1/33),对照组24.24%(8/33),差异具有统计学意义(P<0.05);两组生活质量评分均明显上升,实验组上升幅度更大,差异具有统计学意义(P<0.05);复发率实验组6.25%(2/32),对照组31.82%(7/22),差异具有统计学意义(P<0.05)。[结论]应用康复新液对糜烂性龟头炎进行治疗,可显著提高临床疗效,有效减少不良反应及复发,提高患者生活质量。
〔Objective〕To investigate the clinical effect of Kangfuxin Liquid in treatment of erosive inflammation of the glans penis.〔Methods〕66 cases of erosive glans phlogistic patients admitted were selected as the research object.The experimental group(n=33)and the control group(n=33)were randomly divided.The experimental group was given Kangfuxin Liquid in treatment,The control group was given baiduobang ointment,The clinical efficacy of the two groups was compared,Adverse reactions,Quality of life and relapse.〔Results〕The effective rate of the experimental group was 90.91%(32/33),the control group was 66.67%(22/33),The difference was statistically significant(P<0.05).The incidence of adverse reactions in the experimental group was 3.03%(1/33),Control group was 24.24%(8/33),The difference was statistically significant(P<0.05).The score of quality of life in the two groups increased significantly,The experimental group went up much more,The difference was statistically significant(P<0.05).The recurrence rate of the experimental group was 6.25%(2/32),Control group was 31.82%(7/22),The difference was statistically significant(P<0.05).〔Conclusion〕Application of Kangfuxin Liquid in treatment of erosive balanitis,It can significantly improve the clinical efficacy.Effective reduction of adverse reactions and recurrence,To improve the quality of life of the patients.
作者
李宝印
卜宏民
LI Baoyin;BU Hongmin(Sias International College of Zhengzhou University,Zhengzhou 450062,China;First Affiliated Hospital of Henan University,Kaifeng 475001,China)
出处
《河南大学学报(医学版)》
CAS
2018年第1期46-48,共3页
Journal of Henan University:Medical Science
关键词
康复新液
糜烂性龟头炎
临床疗效
kangfuxin liquid
erosive balanitis
clinical efficacy